86 related articles for article (PubMed ID: 9703867)
1. Effect of interleukin-1 alpha and tumour necrosis factor-alpha on cisplatin-induced ERCC-1 mRNA expression in a human ovarian carcinoma cell line.
Li Q; Bostick-Bruton F; Reed E
Anticancer Res; 1998; 18(4A):2283-7. PubMed ID: 9703867
[TBL] [Abstract][Full Text] [Related]
2. Association between the level of ERCC-1 expression and the repair of cisplatin-induced DNA damage in human ovarian cancer cells.
Li Q; Yu JJ; Mu C; Yunmbam MK; Slavsky D; Cross CL; Bostick-Bruton F; Reed E
Anticancer Res; 2000; 20(2A):645-52. PubMed ID: 10810335
[TBL] [Abstract][Full Text] [Related]
3. Proteasome inhibition suppresses cisplatin-dependent ERCC-1 mRNA expression in human ovarian tumor cells.
Li QQ; Ding L; Reed E
Res Commun Mol Pathol Pharmacol; 2000; 107(5-6):387-96. PubMed ID: 11589365
[TBL] [Abstract][Full Text] [Related]
4. Lactacystin enhances cisplatin sensitivity in resistant human ovarian cancer cell lines via inhibition of DNA repair and ERCC-1 expression.
Li QQ; Yunmbam MK; Zhong X; Yu JJ; Mimnaugh EG; Neckers L; Reed E
Cell Mol Biol (Noisy-le-grand); 2001; 47 Online Pub():OL61-72. PubMed ID: 11936875
[TBL] [Abstract][Full Text] [Related]
5. Modulation of excision repair cross complementation group 1 (ERCC-1) mRNA expression by pharmacological agents in human ovarian carcinoma cells.
Li Q; Tsang B; Bostick-Bruton F; Reed E
Biochem Pharmacol; 1999 Feb; 57(4):347-53. PubMed ID: 9933022
[TBL] [Abstract][Full Text] [Related]
6. Inhibition by 5-fluorouracil of ERCC1 and gamma-glutamylcysteine synthetase messenger RNA expression in a cisplatin-resistant HST-1 human squamous carcinoma cell line.
Fujishima H; Nakano S; Masumoto N; Esaki T; Tatsumoto T; Kondo T; Niho Y
Oncol Res; 1997; 9(4):167-72. PubMed ID: 9268987
[TBL] [Abstract][Full Text] [Related]
7. Cisplatin-induced apoptosis proceeds by caspase-3-dependent and -independent pathways in cisplatin-resistant and -sensitive human ovarian cancer cell lines.
Henkels KM; Turchi JJ
Cancer Res; 1999 Jul; 59(13):3077-83. PubMed ID: 10397248
[TBL] [Abstract][Full Text] [Related]
8. Cisplatin induction of ERCC-1 mRNA expression in A2780/CP70 human ovarian cancer cells.
Li Q; Gardner K; Zhang L; Tsang B; Bostick-Bruton F; Reed E
J Biol Chem; 1998 Sep; 273(36):23419-25. PubMed ID: 9722577
[TBL] [Abstract][Full Text] [Related]
9. Regulation of interleukin-8 gene expression by all-trans retinoic acid.
Harant H; Lindley I; Uthman A; Ballaun C; Krupitza G; Grunt T; Huber H; Dittrich C
Biochem Biophys Res Commun; 1995 May; 210(3):898-906. PubMed ID: 7763262
[TBL] [Abstract][Full Text] [Related]
10. Enhanced cisplatin cytotoxicity by disturbing the nucleotide excision repair pathway in ovarian cancer cell lines.
Selvakumaran M; Pisarcik DA; Bao R; Yeung AT; Hamilton TC
Cancer Res; 2003 Mar; 63(6):1311-6. PubMed ID: 12649192
[TBL] [Abstract][Full Text] [Related]
11. Cisplatin and phorbol ester independently induce ERCC-1 protein in human ovarian carcinoma cells.
Li Q; Ding L; Yu JJ; Mu C; Tsang B; Bostick-Bruton F; Reed E
Int J Oncol; 1998 Nov; 13(5):987-92. PubMed ID: 9772291
[TBL] [Abstract][Full Text] [Related]
12. The inflammatory cytokine tumor necrosis factor-alpha regulates chemokine receptor expression on ovarian cancer cells.
Kulbe H; Hagemann T; Szlosarek PW; Balkwill FR; Wilson JL
Cancer Res; 2005 Nov; 65(22):10355-62. PubMed ID: 16288025
[TBL] [Abstract][Full Text] [Related]
13. Effect of ERCC-1 overexpression on sensitivity of Chinese hamster ovary cells to DNA damaging agents.
Bramson J; Panasci LC
Cancer Res; 1993 Jul; 53(14):3237-40. PubMed ID: 8324733
[TBL] [Abstract][Full Text] [Related]
14. [Enhanced cisplatin cytotoxicity by RNA interfering the excision repair cross-complementing 1 gene in ovarian cancer cell lines].
Liu GY; Qu QX; Mi RR; Qi J
Zhonghua Fu Chan Ke Za Zhi; 2006 May; 41(5):339-42. PubMed ID: 16762192
[TBL] [Abstract][Full Text] [Related]
15. Phorbol ester exposure activates an AP-1-mediated increase in ERCC-1 messenger RNA expression in human ovarian tumor cells.
Li Q; Zhang L; Tsang B; Gardner K; Bostick-Bruton F; Reed E
Cell Mol Life Sci; 1999 Mar; 55(3):456-66. PubMed ID: 10228559
[TBL] [Abstract][Full Text] [Related]
16. Effects of interleukin-1 alpha on DNA repair in human ovarian carcinoma (NIH:OVCAR-3) cells: implications in the mechanism of sensitization of cis-diamminedichloroplatinum(II).
Benchekroun MN; Parker R; Dabholkar M; Reed E; Sinha BK
Mol Pharmacol; 1995 Jun; 47(6):1255-60. PubMed ID: 7603468
[TBL] [Abstract][Full Text] [Related]
17. Effects of RIalpha overexpression on cisplatin sensitivity in human ovarian carcinoma cells.
Cvijic ME; Chin KV
Biochem Biophys Res Commun; 1998 Aug; 249(3):723-7. PubMed ID: 9731205
[TBL] [Abstract][Full Text] [Related]
18. Up-regulation of tumor interleukin-8 expression by infiltrating macrophages: its correlation with tumor angiogenesis and patient survival in non-small cell lung cancer.
Chen JJ; Yao PL; Yuan A; Hong TM; Shun CT; Kuo ML; Lee YC; Yang PC
Clin Cancer Res; 2003 Feb; 9(2):729-37. PubMed ID: 12576442
[TBL] [Abstract][Full Text] [Related]
19. Alterations in the expression of the apurinic/apyrimidinic endonuclease-1/redox factor-1 (APE1/Ref-1) in human ovarian cancer and indentification of the therapeutic potential of APE1/Ref-1 inhibitor.
Zhang Y; Wang J; Xiang D; Wang D; Xin X
Int J Oncol; 2009 Nov; 35(5):1069-79. PubMed ID: 19787261
[TBL] [Abstract][Full Text] [Related]
20. Inhibitor of apoptosis proteins are regulated by tumour necrosis factor-alpha in malignant pleural mesothelioma.
Gordon GJ; Mani M; Mukhopadhyay L; Dong L; Yeap BY; Sugarbaker DJ; Bueno R
J Pathol; 2007 Mar; 211(4):439-46. PubMed ID: 17253597
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
